Skip to main content
. 2017 Aug 15;7:8267. doi: 10.1038/s41598-017-07434-y

Table 3.

Overview of experimental groups.

Treatment Chimeric liver Virus n= Hepatocyte donor
None no None 3 n/a*
yes None 8 HD1, HD2
yes HEV gt1 10 HD1
yes HEV gt3 (HEV0069) 16 HD1, HD2, HD3
yes HEV gt3 (HEV0122) 4 HD1
yes HBV gtA 5 HD3
pegIFNα-2a no None 2 n/a*
yes None 2 HD2
yes HEV gt1 3 HD2
yes HEV gt3 (HEV0069) 11 HD2
yes HBV gtA 6 HD2

*n/a, not applicable.